Anesthesiology Doctors in Fort Mohave, AZ Accepting Medicare

10 Anesthesiology doctors found. Showing 1 - 10

Daniel James Clark, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5330 S Highway 95, Fort Mohave, AZ 86426 Phone: 928-788-7115    Fax: 770-874-5483

Dr. Henry H Liang, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4825 S Highway 95 # 2-356, Fort Mohave, AZ 86426 Phone: 888-206-5902    Fax: 480-466-7536

Fredrick Russek, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 5263 S Highway 95, Suite 101, Fort Mohave, AZ 86426 Phone: 928-788-3333    Fax: 928-788-3555

Oleg V Serbine, M.D. Anesthesiology - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 1510 E Wagon Wheel Ln, Ste. 110, Fort Mohave, AZ 86426 Phone: 928-788-3333    Fax: 928-788-3555

Dr. Mervat Basta, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4825 S Highway 95 # 2-356, Fort Mohave, AZ 86426 Phone: 888-206-5902    Fax: 480-466-7536

Dr. Scott Duong, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4825 S Highway 95 # 2-356, Fort Mohave, AZ 86426 Phone: 888-206-5902    Fax: 480-466-7536

Francisco J. Melo, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4825 S Highway 95 # 2-356, Fort Mohave, AZ 86426 Phone: 888-206-5902    Fax: 480-466-7536

Andres Alvarado, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5330 S Highway 95, Fort Mohave, AZ 86426 Phone: 928-788-2273

Paul T Sutera, M.D. Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1510 E Wagon Wheel Ln Ste 110, Fort Mohave, AZ 86426 Phone: 928-716-7731    Fax: 287-046-0679

Dr. Wade Grindle, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 5330 S Highway 95, Fort Mohave, AZ 86426 Phone: 928-788-7090

News Archive

Lack of motivation in schizophrenia linked to brain chemical imbalance

A study of patients with psychotic illnesses such as schizophrenia suggests an alternative explanation for why many sufferers lack motivation. The research is described in BioMed Central's journal BMC Psychiatry.

Intrinsic subtyping of breast cancer can aid prognosis, treatment of tumor patients

Published in JAMA Oncology, Principal Investigator of Vall d´Hebron Institute of Oncology´s Translational Genomics Group, Team Leader of translational genomics and targeted therapeutics in solid tumors at the August Pi I Sunyer Biomedical Research Institute, and Head of Medical Oncology at the Hospital Clínic in Barcelona, Aleix Prat has led a study showing the intrinsic subtyping of breast cancer by means of a genomic test as the most important prognostic factor in advanced or metastatic hormone-sensitive breast cancer.

Prokarium receives funding to complete pre-clinical development of new Chlamydia vaccine

Prokarium Ltd, a biotechnology company developing transformational oral vaccines, today announced new funding from SynbiCITE, the UK's Innovation and Knowledge Centre for Synthetic Biology.

FDA approves Glassia for treating Alpha 1 deficiency

Kamada, today announced that the United States Food and Drug Administration has approved Glassia (Alpha 1 Proteinase inhibitor, also known as Alpha-1-Antitrypsin) for the treatment of Alpha 1 deficiency. GlassiaM is now the first and only liquid Alpha- 1-Proteinase Inhibitor worldwide available liquid, ready to use, Alpha- 1-Proteinase Inhibitor on the market.

Genetically manipulating rats to emulate Alzheimer's disease in humans

Prof. Claudio Cuello at McGill University and his collaborators have genetically manipulated rats that can emulate Alzheimer's disease in humans, enabling research that will include the development of new treatments. Alzheimer's is a devastating brain condition leading to a progressive decline of memory and other brain functions. Although research mice have been developed in the past, rats are more intelligent than other rodents and the behavior of these rats is rich and predictable, which means that for the first time researchers will be able to detect and study the evolution of learning and memory deficits.

Read more Medical News

› Verified 1 days ago